Rapid Decentralized Prostate Cancer Risk Stratification by Portable Liquid Biopsy Analysis within a Clinical Biosensor Validation Framework.
Saved in:
| Title: | Rapid Decentralized Prostate Cancer Risk Stratification by Portable Liquid Biopsy Analysis within a Clinical Biosensor Validation Framework. |
|---|---|
| Authors: | Koo KM; The University of Queensland Centre for Clinical Research (UQCCR), Brisbane, QLD, Australia.; XING Applied Research & Assay Development (XARAD) Division, XING Technologies Pty Ltd, Brisbane, QLD, Australia.; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, Australia., Phillips G; XING Applied Research & Assay Development (XARAD) Division, XING Technologies Pty Ltd, Brisbane, QLD, Australia., Srihari S; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Farrell Á; The University of Queensland Centre for Clinical Research (UQCCR), Brisbane, QLD, Australia., Jaradi B; XING Applied Research & Assay Development (XARAD) Division, XING Technologies Pty Ltd, Brisbane, QLD, Australia., Fitzpatrick KJ; XING Applied Research & Assay Development (XARAD) Division, XING Technologies Pty Ltd, Brisbane, QLD, Australia., Yaxley JW; The University of Queensland Centre for Clinical Research (UQCCR), Brisbane, QLD, Australia.; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia., Samaratunga H; The University of Queensland Centre for Clinical Research (UQCCR), Brisbane, QLD, Australia.; Aquesta Specialized Uropathology, Brisbane, QLD, Australia.; Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD, Australia., Mainwaring PN; XING Applied Research & Assay Development (XARAD) Division, XING Technologies Pty Ltd, Brisbane, QLD, Australia., Ru KL; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, Australia., Korbie DJ; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, Australia., Tomlins SA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.; Strata Oncology, Ann Arbor, MI, USA., Roberts MJ; The University of Queensland Centre for Clinical Research (UQCCR), Brisbane, QLD, Australia.; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.; Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD, Australia., Gardiner RA; The University of Queensland Centre for Clinical Research (UQCCR), Brisbane, QLD, Australia.; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.; Edith Cowan University, Perth, WA, Australia., Trau M; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, Australia.; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia. |
| Source: | Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2026 Mar; Vol. 13 (13), pp. e12126. Date of Electronic Publication: 2026 Jan 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844 (Electronic) Linking ISSN: 21983844 NLM ISO Abbreviation: Adv Sci (Weinh) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2198-3844 |
|---|---|
| DOI: | 10.1002/advs.202512126 |
